PRPO – Precipio Inc
Precipio, Inc.PRPO
$23.32Name : Precipio, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $41,681,516.00
EPSttm : -0.45
Precipio, Inc.
$23.32
1.39%$0.32
PRPO — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
0.94
Margin Of Safety %
-11
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
23.44
Target Price
19
Analyst Recom
1
Performance Q
-12
Upside
-129.0%
Beta
1.28
Ticker: PRPO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-05-11 | PRPO | 28.245 | N/A | N/A | 0 |
| 2026-05-12 | PRPO | 28.49 | N/A | N/A | 0 |
| 2026-05-13 | PRPO | 28.35 | N/A | N/A | 0 |
| 2026-05-14 | PRPO | 28.5 | N/A | N/A | 0 |
| 2026-05-15 | PRPO | 26.25 | N/A | N/A | 0 |
| 2026-05-18 | PRPO | 25.38 | N/A | N/A | 0 |
| 2026-05-19 | PRPO | 25.48 | N/A | N/A | 0 |
| 2026-05-20 | PRPO | 24.43 | N/A | N/A | 0 |
| 2026-05-21 | PRPO | 24.785 | N/A | N/A | 0 |
| 2026-05-22 | PRPO | 23.89 | N/A | N/A | 0 |
| 2026-05-26 | PRPO | 24.82 | N/A | N/A | 0 |
| 2026-05-27 | PRPO | 23.6 | N/A | N/A | 0 |
| 2026-05-28 | PRPO | 23.32 | N/A | N/A | 0 |
| 2026-05-29 | PRPO | 22.8 | N/A | N/A | 0 |
| 2026-06-02 | PRPO | 22.6 | N/A | N/A | 0 |
| 2026-06-03 | PRPO | 24.04 | N/A | N/A | 0 |
| 2026-06-04 | PRPO | 23.78 | N/A | N/A | 0 |
| 2026-06-05 | PRPO | 23.68 | N/A | N/A | 0 |
| 2026-06-08 | PRPO | 23.2 | N/A | N/A | 0 |
| 2026-06-09 | PRPO | 23.44 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-05-11 | PRPO | 28.36 | - | - | - |
| 2026-05-12 | PRPO | 28.55 | - | - | - |
| 2026-05-13 | PRPO | 28.35 | - | - | - |
| 2026-05-14 | PRPO | 28.33 | - | - | - |
| 2026-05-15 | PRPO | 26.25 | - | - | - |
| 2026-05-18 | PRPO | 24.94 | - | - | - |
| 2026-05-19 | PRPO | 25.48 | - | - | - |
| 2026-05-20 | PRPO | 24.44 | - | - | - |
| 2026-05-21 | PRPO | 24.80 | - | - | - |
| 2026-05-22 | PRPO | 23.76 | - | - | - |
| 2026-05-26 | PRPO | 24.38 | - | - | - |
| 2026-05-27 | PRPO | 23.72 | - | - | - |
| 2026-05-28 | PRPO | 23.86 | - | - | - |
| 2026-05-29 | PRPO | 23.17 | - | - | - |
| 2026-06-01 | PRPO | 22.60 | - | - | - |
| 2026-06-02 | PRPO | 22.21 | - | - | - |
| 2026-06-03 | PRPO | 24.04 | - | - | - |
| 2026-06-04 | PRPO | 23.46 | - | - | - |
| 2026-06-05 | PRPO | 23.68 | - | - | - |
| 2026-06-08 | PRPO | 23.08 | - | - | - |
| 2026-06-09 | PRPO | 23.44 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-05-11 | PRPO | 0.06 | -3.98 | 0.55 |
| 2026-05-12 | PRPO | 0.06 | -3.98 | 0.43 |
| 2026-05-13 | PRPO | 0.06 | -3.98 | 0.43 |
| 2026-05-14 | PRPO | 0.06 | -3.98 | 0.43 |
| 2026-05-15 | PRPO | 0.06 | -3.98 | 0.43 |
| 2026-05-18 | PRPO | 0.06 | -3.97 | 0.43 |
| 2026-05-19 | PRPO | 0.07 | -3.97 | 0.43 |
| 2026-05-20 | PRPO | 0.07 | -3.97 | 0.43 |
| 2026-05-21 | PRPO | -2.09 | -3.97 | 0.43 |
| 2026-05-22 | PRPO | -2.09 | -3.97 | 0.43 |
| 2026-05-26 | PRPO | -2.68 | 0.96 | 0.43 |
| 2026-05-27 | PRPO | -2.68 | 0.96 | 0.43 |
| 2026-05-28 | PRPO | -2.68 | 0.96 | 0.89 |
| 2026-05-29 | PRPO | -2.68 | 0.96 | 0.89 |
| 2026-06-02 | PRPO | -1.76 | -0.46 | 0.94 |
| 2026-06-03 | PRPO | -1.76 | -0.46 | 0.94 |
| 2026-06-04 | PRPO | -1.76 | -0.46 | 0.94 |
| 2026-06-05 | PRPO | -1.76 | -0.46 | 0.94 |
| 2026-06-08 | PRPO | -1.76 | -0.41 | 0.94 |
| 2026-06-09 | PRPO | -1.76 | -0.41 | 0.94 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
-1.76
Institutional Transactions
-0.41
Beta
1.28
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
20.86
Quality Score
49
Growth Score
52
Sentiment Score
97
Actual DrawDown %
74.8
Max Drawdown 5-Year %
-94.7
Target Price
19
P/E
Forward P/E
PEG
P/S
1.61
P/B
2.94
P/Free Cash Flow
74.43
EPS
-0.52
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-3.57
Relative Volume
0.73
Return on Equity vs Sector %
-34
Return on Equity vs Industry %
-17.3
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
PRPO
Healthcare
$23.32
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
39.7
Range 1M
21%
Sup Dist
3.4%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
0%
EPS NY
0%
52W%
55.8%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-13.7% upside
Upside
-13.7%
Quality
49
MoS
-11%
Precipio, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 61
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
PRPO
Latest News
—
Caricamento notizie per PRPO…
stock quote shares PRPO – Precipio Inc Stock Price stock today
news today PRPO – Precipio Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRPO – Precipio Inc yahoo finance google finance
stock history PRPO – Precipio Inc invest stock market
stock prices PRPO premarket after hours
ticker PRPO fair value insiders trading